Zhengye Biotechnology Holding Limited (ZYBT)
Zhengye Biotechnology Holding Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Jilin, JI, CN. The stock last traded at $1.55, down 3.73% on the session, giving a market capitalisation of $73.5M. On trailing twelve-month figures it carries a trailing P/E of -7.00, a net margin of -89.0%. Its beta of -2.69 implies it has historically moved less than the broad market.
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
Zhengye Biotechnology Holding Limited is most often compared with the following Healthcare names: